nisoldipine has been researched along with Aging in 7 studies
Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nisoldipine is a second-generation dihydropyridine calcium channel blocker (CCB)." | 6.40 | Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease. ( Fodor, JG, 1997) |
| " Calcium antagonists, including verapamil, are now used widely in the management of patients with hypertension." | 3.67 | Calcium antagonists and hypertension. ( Dillon, JS; Nayler, WG; Sturrock, WJ, 1988) |
| "Nisoldipine is a second-generation dihydropyridine calcium channel blocker (CCB)." | 2.40 | Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease. ( Fodor, JG, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fodor, JG | 1 |
| Anyukhovsky, EP | 1 |
| Sosunov, EA | 1 |
| Plotnikov, A | 1 |
| Gainullin, RZ | 1 |
| Jhang, JS | 1 |
| Marboe, CC | 1 |
| Rosen, MR | 1 |
| Liu, W | 1 |
| Yasui, K | 1 |
| Opthof, T | 1 |
| Ishiki, R | 1 |
| Lee, JK | 1 |
| Kamiya, K | 1 |
| Yokota, M | 1 |
| Kodama, I | 1 |
| Baksi, AK | 1 |
| Edwards, JS | 1 |
| Ahr, G | 1 |
| Imai, Y | 1 |
| Abe, K | 1 |
| Sasaki, S | 1 |
| Minami, N | 1 |
| Nihei, M | 1 |
| Munakata, M | 1 |
| Sakuma, H | 1 |
| Hashimoto, J | 1 |
| Imai, K | 1 |
| Sekino, H | 1 |
| van Harten, J | 1 |
| Burggraaf, J | 1 |
| Ligthart, GJ | 1 |
| van Brummelen, P | 1 |
| Breimer, DD | 1 |
| Nayler, WG | 1 |
| Dillon, JS | 1 |
| Sturrock, WJ | 1 |
1 review available for nisoldipine and Aging
| Article | Year |
|---|---|
Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease.
Topics: Aging; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Delayed-A | 1997 |
6 other studies available for nisoldipine and Aging
| Article | Year |
|---|---|
Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2002 |
Developmental changes of Ca(2+) handling in mouse ventricular cells from early embryo to adulthood.
Topics: Aging; Animals; Anti-Arrhythmia Agents; Calcium; Calcium Channel Blockers; Calcium-Binding Proteins; | 2002 |
A comparison of the pharmacokinetics of nisoldipine in elderly and young subjects.
Topics: Adult; Aged; Aging; Biological Availability; Blood Pressure; Female; Heart Rate; Humans; Male; Middl | 1991 |
Influence of age on the nocturnal fall of blood pressure and its modulation by long-acting calcium antagonists.
Topics: Aging; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Humans; Monitoring, Physiologic; | 1990 |
Single- and multiple-dose nisoldipine kinetics and effects in the young, the middle-aged, and the elderly.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aging; Blood Pressure; Dose-Response Relations | 1989 |
Calcium antagonists and hypertension.
Topics: Aging; Aniline Compounds; Animals; Blood Pressure; Calcium Channel Blockers; Catecholamines; Dihydro | 1988 |